Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | KIF11 | P52732 | 3/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TYR | P14679 | 1/20 | 0.35 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7525355 | 0.86 | ALDH1A1 (0.42) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL16351784 | 0.81 | GPR84 (0.38) | ALDH1A1HPGDHSD17B10MEN1GAA | |
| SCHEMBL30117491 | 0.81 | GPR84 (0.38) | ALDH1A1HPGDHSD17B10MEN1GAA | |
| SCHEMBL722323 | 0.78 | ALDH1A1 (0.57) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL27241188 | 0.78 | NR1I2 (0.39) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL31107047 | 0.78 | GABRA1 (0.33) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL24276292 | 0.75 | KIF11 (0.44) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL20043182 | 0.74 | KCNH2 (0.42) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL15947198 | 0.74 | CA2 (0.55) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL29951609 | 0.74 | CA2 (0.55) | ALDH1A1HPGDALOX15HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9315460-B2 | Organic compound, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2016-04-19 | — | — | US | disclosed |
| US-9315460-B2 | Organic compound, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2016-04-19 | — | — | US | disclosed |
| US-9005778-B2 | Organic compound and organic light-emitting device including the same | CANON KABUSHIKI KAISHA (JP) | 2015-04-14 | — | — | US | disclosed |
| US-9005778-B2 | Organic compound and organic light-emitting device including the same | CANON KABUSHIKI KAISHA (JP) | 2015-04-14 | — | — | US | disclosed |
| US-8940413-B2 | Organic compound having acenaphtho[1,2-k]benzo[e]acephenanthrene derivative, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2015-01-27 | — | — | US | disclosed |
| US-8940413-B2 | Organic compound having acenaphtho[1,2-k]benzo[e]acephenanthrene derivative, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2015-01-27 | — | — | US | disclosed |
| US-20140374738-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KK (JP) | 2014-12-25 | — | — | US | disclosed |
| US-20140374738-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KK (JP) | 2014-12-25 | — | — | US | disclosed |
| EP-2569268-B1 | NOVEL ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CANON KK (JP) | 2014-11-05 | — | — | EP | disclosed |
| US-20130038515-A1 | NOVEL ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2013-02-14 | — | — | US | disclosed |
| US-20130038515-A1 | NOVEL ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2013-02-14 | — | — | US | disclosed |
| US-20120025183-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20120025183-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20110315973-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2011-12-29 | — | — | US | disclosed |
| US-20110315973-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2011-12-29 | — | — | US | disclosed |
| WO-2011136155-A1 | NOVEL ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2011-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110315973-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | NR2E3, PYM1, TYR | ALDH1A1 1824/4885HPGD 2624/4885ALOX15 967/4885 |
| US-20120025183-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | ACE, ACE2, AGTR1 | ALDH1A1 218/4885HPGD 2925/4885ALOX15 1653/4885 |
| US-20130038515-A1 | NOVEL ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | TYR, CYP3A4, DDT | ALDH1A1 198/4885HPGD 2362/4885ALOX15 352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.